Analysis of T cell composition within tumor samples in 102 patients with classical HL, where 29% of the tumor samples were positive for LMP1 by immunohistochemistry, demonstrated higher numbers of CD8+ T cells and CD4+/FoxP3+ T regs in samples from EBV-positive tumors (114). The gene discussed is CD8A; the disease is neoplasm.